Practical considerations for treating HF with mildly reduced and preserved EF.

Back

Open Access

Practical considerations for treating HF with mildly reduced and preserved EF.

Session: SGLT-2 inhibitors - Another piece of the puzzle in heart failure

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Professor C. Lam (Singapore, SG)

Organised by Radcliffe Medical Education - Supported by an unrestricted educational grant from AstraZeneca

Event: ESC Congress 2022

Congress Presentation

About the speaker

Professor Carolyn Sp Lam

Duke-NUS Graduate Medical School Singapore, Singapore (Singapore)

150 presentations

51 followers

5 more presentations in this session

SGLT2 inhibitors in HFpEF - Light at the end of the tunnel.

Speaker: Professor S. Solomon (Boston, US)

Access

Slides

Video

SGLT2 inhibitors across the spectrum of heart failure.

Speaker: Professor J. McMurray (Glasgow, GB)

Access

Slides

Video

Implementing best practices across the spectrum of heart failure.

Speaker: Doctor M. Vaduganathan (Boston, Massachusetts, US)

Access

Slides

Video

Summary.

Access

Slides

Video

Discussion.

Access

Video

Access the full session

SGLT-2 inhibitors - Another piece of the puzzle in heart failure

Speakers: Professor C. Lam, Professor S. Solomon, Professor J. McMurray, Doctor M. Vaduganathan

Access

Video

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

Practical considerations for treating HF with mildly reduced and preserved EF.

About the speaker

Professor Carolyn Sp Lam

5 more presentations in this session

SGLT2 inhibitors in HFpEF - Light at the end of the tunnel.

SGLT2 inhibitors across the spectrum of heart failure.

Implementing best practices across the spectrum of heart failure.

Summary.

Discussion.

Access the full session

SGLT-2 inhibitors - Another piece of the puzzle in heart failure

About the event

ESC Congress 2022

ESC 365 is supported by